RxDoctor Payments Data

Angela Casolari

Family · Flora, ILNPI 1316338890

Payments from drug & device makers

$800in general payments, 2019–2025

Across 49 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$340
  • Novo Nordisk$211
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$91
  • Mylan Specialty L.p.$49
  • GSK$25
  • Eisai Inc.$22
  • plus $64 from 4 others

What the payments were for

  • Food & beverage$800100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$800 in reported general payments places this provider in the 70th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$1,797
Medicare patients
28
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$70,685
JardianceEmpagliflozin58$64,635
EliquisApixaban60$46,274
TrulicityDulaglutide24$37,580
TradjentaLinagliptin38$31,536
Repatha SureclickEvolocumab18$13,620
JanuviaSitagliptin Phosphate21$12,832
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$12,376
Breo ElliptaFluticasone/Vilanterol20$11,767
MounjaroTirzepatide11$10,576
Metformin Hcl108$8,876
EntrestoSacubitril/Valsartan12$8,264
Incruse ElliptaUmeclidinium Bromide23$7,928
Pantoprazole Sodium343$7,778
Scopolamine50$6,729

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$211$70,68547 claims
Lilly USA, LLCTrulicity, Mounjaro$340$48,15635 claims
PfizerEliquis$18$46,27460 claims
GSKAnoro Ellipta, Breo Ellipta, Incruse Ellipta$25$32,07164 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,941 family providers in Illinois.

Other family in Flora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →